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ORIGINAL ARTICLE
For efficient IABP support, the correct timing of IAB infla-
tion and deflation is vital (3). Current convention is for the on-
set of inflation to coincide with aortic valve closure, as land-
marked by the dicrotic notch, while deflation must start shortly 
before the onset of the following systole. Without a suitable 
visual marker to guide the latter setting, the onset of defla-
tion is usually fine-tuned to generate the largest reduction in 
end-diastolic aortic pressure. Due to the sheer number of vascu-
lar, ventricular, and coronary parameters of interest, thorough 
in vivo studies of the hemodynamic consequences of non-
conventional IAB trigger timing are challenging to conduct (4). 
Earlier reports focus on a subset of hemodynamic parameters 
and inflation/deflation trigger timings (3, 5, 6). Nonetheless, it 
is generally thought that early inflation and late deflation can 
be detrimental because they disrupt LV ejection, during the 
preceding late systole and the following early systole, respec-
tively. Instead, late inflation and early deflation are considered 
suboptimal in terms of therapeutic benefit, but not hazardous.
Assistance frequency is another time-related IABP operat-
ing parameter. During IABP weaning, the operator can select 
the assistance frequency delivered to the patient and can opt 
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Introduction
The intra-aortic balloon pump (IABP) provides circulatory 
support to the failing heart through counterpulsation (1, 2). 
Positioned in the descending thoracic aorta, the intra-aortic 
balloon (IAB) is inflated in early diastole, enhancing coronary 
blood flow through an increase in diastolic aortic pressure. 
IAB deflation in late diastole reduces end-diastolic aortic 
pressure and consequently left ventricular (LV) afterload, wall 
tension and myocardial oxygen demand.
ABSTRACT
Purpose: The intra-aortic balloon pump (IABP) provides circulatory support through counterpulsation. The hemo-
dynamic effects of the IABP may vary with assisting frequency and depend on IAB inflation/deflation timing. We 
aimed to assess in vivo the IABP benefits on coronary, aortic, and left ventricular hemodynamics at different assis-
tance frequencies and trigger timings.
Methods: Six healthy, anesthetized, open-chest sheep received IABP support at 5 timing modes (EC, LC, CC, 
CE, CL, corresponding to early/late/conventional/conventional/conventional inflation and conventional/conven-
tional/conventional/early/late deflation, respectively) with frequency 1:3 and 1:1. Aortic (Q
ao
) and coronary (Q
cor
) 
flow, and aortic (P
ao
) and left ventricular (P
LV
) pressure were recorded simultaneously, with and without IABP sup-
port. Integrating systolic Q
ao
 yielded stroke volume (SV).
Results: EC at 1:1 produced the lowest end-diastolic P
ao
 (59.5 ± 7.8 mmHg [EC], 63.4 ± 11.1 mmHg [CC]), CC at 1:1 
the lowest systolic P
LV
 (69.1 ± 6.5 mmHg [CC], 76.4 ± 6.5 mmHg [control]), CC at 1:1 the highest SV (88.5 ± 34.4 ml 
[CC], 76.6 ± 31.9 ml [control]) and CC at 1:3 the highest diastolic Q
cor
 (187.2 ± 25.0 ml/min [CC], 149.9 ± 16.6 ml/min 
[control]). Diastolic P
ao
 augmentation was enhanced by both assistance frequencies alike, and optimal timings were 
EC for 1:3 (10.4 ± 2.8 mmHg [EC], 6.7 ± 3.8 mmHg [CC]) and CC for 1:1 (10.8 ± 6.7 mmHg [CC], -3.0 ± 3.8 mmHg 
[control]).
Conclusions: In our experiments, neither a single frequency nor a single inflation/deflation timing, including 
conventional IAB timing, has shown superiority by uniformly benefiting all studied hemodynamic parameters. A 
choice of optimal frequency and IAB timing might need to be made based on individual patient hemodynamic 
needs rather than as a generalized protocol.
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for switching from full assistance to partial assistance (support 
provided every heart beat (1:1) or every second/third/fourth 
(1:2/1:3/1:4) beat, respectively). It is generally assumed that 
the hemodynamic benefits of full and partial support per 
supported beat are alike. Namely, that a single beat from 
a 1:1 sequence and the supported beat from a 1:2/1:3/1:4 
sequence provide equivalent assistance to the patient, and 
thus that the latter sequences are simply a “diluted” (over 
time) form of 1:1, consisting of a supported beat equivalent 
to those found in 1:1 and a series of 1/2/3 unassisted beats. 
However, coronary autoregulatory controls and barorecep-
tor reflexes might respond differently to different assistance 
modes and evidence has emerged lately that full support is 
superior (5, 7). Nevertheless, a comparison between the ben-
efits of isolated supported beats at different frequencies, and 
the effect of support frequency in conjunction with the effect 
of trigger timing have not been studied before.
The main aim of the present study was to investigate in 
healthy sheep the combined effect of varying assistance fre-
quency and IAB inflation/deflation timing on coronary, aortic, 
and LV hemodynamics. We hypothesized that an assistance 
frequency of 1:1 will be associated with superior indices of 
hemodynamic function. We also hypothesized that non-con-
ventional IAB trigger timings might yield better hemodynamic 
benefits compared to conventional timing.
Materials and Methods
Animal model
Acute animal studies were performed on six adult, Q-fever- 
negative, Dorset sheep (70 ± 15 kg, 4 male). This model was 
selected because its cardiovascular dimensions and baseline 
hemodynamic values are similar to those of human adults, and 
it has been successfully used for assessment of cardiac assist 
device performance in heart failure (8).
All animals received humane care in accordance with the 
Guide for Care and Use of Laboratory Animals (NIH publica-
tion 85-23, revised 1996). The protocol was approved by the 
Institutional Animal Care and Use Committee of the Univer-
sity of Louisville.
Animal preparation and instrumentation
Each pre-fasted animal was pre-medicated with xylazine 
(0.02-0.03 mg/kg, IM) before surgery. Anesthesia was in-
duced with valium (0.2-0.4 mg/kg IV) and ketamine (4-8 mg/
kg, IV) through the auricular vein. Following intubation, gen-
eral anesthesia was maintained with isoflurane inhalation 
(0.5-3%) in 100% oxygen throughout the procedure, follow-
ing standard protocol at the Cardiovascular Innovation Insti-
tute (CII). Vital signs were continuously monitored and hourly 
blood gas analysis guided ventilator management.
With the animal in the recumbent position, the right 
femoral vein and left femoral artery were exposed. A fluid-
filled catheter was inserted into the right femoral vein and 
the left femoral artery was isolated for later insertion of the 
IAB catheter.
After repositioning in lateral recumbency, the heart, aortic 
arch, and descending thoracic aorta were exposed with a left 
lateral thoracotomy at the fourth intercostal space. A high fi-
delity 5 Fr dual-pressure-sensor catheter (Millar Instruments, 
Houston, TX, USA) was inserted into the ascending aorta 
and advanced retrograde across the aortic valve until the tip 
transducer was inside the LV and the proximal transducer in 
the ascending aorta. Transit-time ultrasonic perivascular flow 
probes (Transonic Systems, Ithaca, NY, USA) were securely 
fitted around the ascending aorta and the left anterior de-
scending artery. A second high-fidelity 5 Fr pressure-sensor 
catheter (Millar Instruments) was inserted into the distal end 
of the aortic arch, with the transducer positioned where the 
IAB catheter tip was anticipated to extend.
Following an IV bolus injection of heparin (225 IU/kg), a 
Fidelity 9.5 Fr 40 cc IAB catheter (Datascope, Fairfield, NJ, USA) 
was introduced in the left femoral artery. Under fluoroscopy, 
the IAB catheter was advanced towards the aortic arch until its 
tip was about 2 cm distal to the subclavian artery, while radi-
opaque dye injection through the innominate trunk confirmed 
that the balloon was situated in its entirety in the descending 
thoracic aorta. The IAB catheter was connected to a Datascope 
98XT IABP console (Datascope, Fairfield, NJ, USA).
Measurements and protocol
Aortic (P
ao
) and LV pressure (P
LV
), aortic (Q
ao
) and coronary 
flow (Q
cor
), and the ECG were recorded at 500 Hz, as well as 
IAB catheter shuttle gas pressure (P
shuttle
) (provided by the 
IABP console output). The aortic pressure waveform recorded 
close to the IAB tip guided IABP operation (9).
The animals were randomly divided into two groups: 
‘1:1’ group (n = 3) and ‘1:3’ group (n = 3), receiving 1:1 and 
1:3 IABP support, respectively. For each animal, the protocol 
consisted of a series of measurements during counterpulsa-
tion, followed by measurements with the IABP at standby 
(baseline), and was repeated three times for the 1:3 group and 
once for the 1:1 group. The counterpulsation measurements 
comprised a randomized sequence of approximately 30-sec-
ond segments, each segment corresponding to different IABP 
inflation and deflation timing. Apart from conventional onset 
of inflation and deflation, earlier- and later-than-conventional 
onsets were produced through the IABP controls. In total 3 to 
5 inflation and 3 to 5 deflation timings and various combina-
tions between them were tested. The ventilator was turned off 
during data recording.
Data analysis
All data processing was done in Matlab (version R2011b, 
MathWorks, Natick, MA, USA). P
ao
 and Q
ao
 were smoothed us-
ing a 3rd order Savitzky-Golay filter (10). Aortic flow velocity 
(U
ao
) was derived from Q
ao
 by dividing with the nominal area 
of the aortic flow probe. Hardware-induced time lags between 
P
ao
 and U
ao
 were corrected using the PU-loop method (11).
Two representative and non-consecutive assisted beats 
(assisted beats) were selected from each 30-second segment 
and from each baseline (control beats) for further analysis. For 
the 1:3 group the beats following the assisted beats (follow-
ing beats) were also interrogated. Simultaneous inspection of 
P
ao
, P
shuttle
, and ECG for each assisted beat enabled the quanti-
fication of onset of inflation and deflation, with respect to the 
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preceding and the following R-wave, respectively. These times 
were normalized to the duration of the beat and grouped as 
early (E), late (L), and conventional (C) inflation and deflation. 
Five inflation-deflation trigger timing combinations were in-
vestigated further: C-C (CC), E-C (EC), L-C (LC), C-E (CE) and C-L 
(CL). Table I presents the mean normalized inflation and defla-
tion times and the total number of analyzed beats for each of 
the 5 interventions.
For each analyzed beat, averages per beat as well as sys-
tolic (S) and diastolic (D) averages were derived for P
ao
, Q
ao
, P
LV
, 
and Q
cor
. Diastolic aortic pressure augmentation (P
aug
) was de-
termined by subtracting maximum systolic P
ao
 from maximum 
diastolic P
ao
 (Fig. 1B). End-diastolic P
ao
 (edP
ao
) was defined as 
P
ao
 immediately prior to aortic valve opening (Fig. 1B). Stroke 
volume (SV) was calculated from Q
ao
 by integrating the positive 
flow from aortic valve opening until flow reversal at the end of 
systole (Fig. 1A). Integration of the subsequent negative aortic 
flow until flow reversal or until a second acceleration phase in 
negative flow (whichever occurred first), yielded a measure of 
initial aortic backflow surge (Fig. 1A).
TABLE I - Times and aortic pressure parameters
n Time inflation Time deflation P
aug
edP
ao
(mmHg) (mmHg)
 EC 1:1 10 0.35 ± 0.07 -0.12 ± 0.02 13.1 ± 5.0* 59.5 ± 7.8*¶$
 EC 1:3 18 0.38 ± 0.07 -0.07 ± 0.02 10.4 ± 2.8*$# 63.4 ± 14.6#
Following 1:3 18 -10.6 ± 7.1 56.6 ± 10.1
 LC 1:1 8 0.60 ± 0.04 -0.08 ± 0.05 9.7 ± 6.2*$ 61.8 ± 5.2*¶
 LC 1:3 18 0.62 ± 0.10 -0.08 ± 0.03 4.1 ± 3.9*$# 62.8 ± 13.9*#
Following 1:3 18 -7.8 ± 4.3 57.6 ± 9.3
 CC 1:1 10 0.51 ± 0.04 -0.08 ± 0.05 10.8 ± 6.7* 63.4 ± 11.1¶
 CC 1:3 19 0.50 ± 0.08 -0.07 ± 0.03 6.7 ± 3.8*# 63.8 ± 14.2#
Following 1:3 19 -8.9 ± 5.1 57.9 ± 10.2
 CE 1:1 10 0.52 ± 0.04 -0.19 ± 0.04 14.4 ± 5.8* 65.9 ± 10.0*
 CE 1:3 34 0.49 ± 0.09 -0.24 ± 0.05 5.8 ± 4.4*#$ 57.1 ± 10.9$
Following 1:3 34 -6.1 ± 6.0 58.4 ± 9.5
 CL 1:1 4 0.51 ± 0.06 0.03 ± 0.01 5.2 ± 1.9 70.9 ± 2.2
 CL 1:3 2 0.60 ± 0.01 0.05 ± 0.01 5.8 ± 0.3 61.5 ± 0.5
Following 1:3 2 -20.2 ± 0.3 41.8 ± 0.0
control 1:1 33 -3.0 ± 3.8 68.8 ± 9.6
control 1:3 18 -6.2 ± 5.4 57.5 ± 12.0
Values are mean ± standard deviation. P
aug
 = Diastolic aortic pressure augmentation; edP
ao
 = End-diastolic aortic pressure; EC/CC/LC = Early/conven-
tional/late inflation and conventional deflation timing; CE/CC/CL = Conventional inflation and early/conventional/late deflation timing; n = Number of 
individual beats. * = P<0.05 compared to control; ¶ = P<0.05 compared to 1:3; $ = P<0.05 compared to CC; # = P<0.05 compared to the following beat  
(1:3 group only).
Fig. 1 - Hemodynamic signals for a beat with conventional IABP tim-
ing and its following beat at assistance frequency 1:3. (A) Aortic flow 
(Q
ao
) and calculation of stroke volume (SV) and backflow; (B) Aortic 
pressure (P
ao
, black), left ventricular pressure (P
LV
, grey) and deter-
mination of diastolic P
ao
 augmentation (P
aug
) and end-diastolic aortic 
pressure (edP
ao
).
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With reference to the 1:3 group, throughout this study we 
consistently use the term “assisted beat” to refer to a heart 
cycle during the diastole of which the IABP operates and the 
term “following beat” to refer to the beat that succeeds it. 
However, strictly speaking, during 1:3 support it is only the di-
astole of the assisted beat that is assisted (through inflation), 
since during the preceding systole the IABP was not operating 
yet. The effect of counterpulsation on primarily systolic param-
eters (such as P
LV
, SP
LV
, SV, and SQ
cor
) will be therefore revealed 
on the following beat (through deflation). To reflect this and 
contrary to the strict use of the terms “assisted beat” and “fol-
lowing beat”, we reserve the terms “with IABP support” and 
“without IABP support” to be used without any presumption 
about their association to assisted or following beats.
Statistical analysis
All statistical analysis was performed in MLwiN (version 
2.27, Centre for Multilevel Modelling, University of Bristol, 
Bristol, UK) (12). The values reported are mean ± standard 
deviation. For all parameters of interest, we compared: 1) 
values with IABP support and control values (separately for 
the 1:1 and 1:3 groups); 2) values with and without IABP sup-
port in successive beats (1:3 group only); 3) values with IABP 
support at CC with EC, LC and CE (separately for the 1:1 and 
1:3 groups); and 4) values with IABP support between the 1:1 
and 1:3 groups, after adjusting for possible baseline varia-
tions between the two groups. The statistical comparisons 
were performed with mixed model analysis (12). Statistical 
significance was assumed at P<0.05.
CL trigger timing, with late deflation defined as onset of 
deflation after the R-wave, was achieved only in half of the 
animals and no statistical testing could be performed.
Results
Hemodynamic signals
Figure 2 shows typical examples, from a single animal 
of the 1:3 group, of the P
ao
, Q
ao
, P
LV
, and Q
cor
 contours and 
their divergence between C, E, and L inflation (Fig. 2A) and 
between C, E and L deflation (Fig. 2B). The effect of the vari-
ous trigger interventions is noticeable in the shape of the P
ao
 
waveform, which drastically changes according to the time 
diastolic pressure starts to increase and decrease due to IAB 
inflation and deflation, respectively. The Q
cor
 signal also pro-
vides visual evidence of an increase in DQ
cor
 at all timing inter-
ventions. Differences in the P
LV
 and Q
ao
 shapes between the 
different conditions are more subtle.
Hemodynamic parameters
Tables I and II summarize the mean values of the various 
hemodynamic parameters that were studied. A complete 
overview of the results of the statistical analysis is also pro-
vided in the tables.
There was no difference in P
aug
 between the two assis-
tance frequencies and a performance superior to CC was 
achieved only by EC at 1:3 (10.4 ± 2.8 mmHg [EC], 6.7 ± 
3.8 mmHg [CC]). Support frequency 1:1 outperformed 1:3 
Fig. 2 - Hemodynamic data col-
lected during 1:3 support for an 
assisted beat and its following beat 
for different IABP inflation (A) and 
deflation trigger timings (B). Top 
panels: Aortic flow (Q
ao
, black) and 
coronary flow (Q
cor
, filled grey); Bot-
tom panels: Aortic pressure (P
ao
, 
black) and left ventricular pressure 
(P
LV
, grey). EC/CC/LC: Early/conven-
tional/late inflation and conven-
tional deflation timing; CE/CC/CL: 
Conventional inflation and early/
conventional/late deflation timing.
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TABLE II - Flow and left ventricular pressure parameters
PLV DPLV SPLV SV Backflow Qcor DQcor SQcor
(mmHg) (mmHg) (mmHg) (ml) (ml) (ml/min) (ml/min) (ml/min)
 EC 1:1 41.9 ± 5.2*¶ 18.6 ± 5.1*$ 68.9 ± 5.0*¶ 78.1 ± 27.9$ 4.4 ± 0.9*¶$ 92.6 ± 8.7*$ 148.5 ± 5.9¶$ 24.4 ± 11.4*$
 EC 1:3 39.0 ± 6.2 13.6 ± 5.1$# 66.8 ± 10.5 67.4 ± 16.2# 3.0 ± 0.3*# 104.4 ± 23.5*$# 181.9 ± 16.7*# 27.2 ± 17.1
Following 1:3 40.8 ± 7.6$ 12.0 ± 4.2 67.7 ± 10.9$ 71.9 ± 14.6 1.7 ± 0.3 74.8 ± 26.1 143.8 ± 13.1 20.4 ± 24.7
 LC 1:1 40.3 ± 3.9*¶ 14.7 ± 2.1 67.2 ± 4.5*¶ 78.1 ± 32.6¶ 3.1 ± 0.7 75.1 ± 13.6*$ 138.4 ± 6.6*¶$ 4.1 ± 21.5*¶$
 LC 1:3 39.8 ± 6.7# 12.1 ± 4.8 66.8 ± 10.1# 68.8 ± 15.8# 1.9 ± 0.4 94.0 ± 26.5*$# 176.7 ± 19.8*$# 23.8 ± 19.2#
Following 1:3 39.2 ± 6.8 11.6 ± 3.9 66.0 ± 10.2 70.1 ± 15.4$ 1.8 ± 0.4 75.0 ± 27.1 144.5 ± 17.4 17.0 ± 23.4*
 CC 1:1 42.6 ± 6.3*¶ 14.9 ± 3.1* 69.1 ± 6.5*¶ 88.5 ± 34.4* 3.6 ± 1.5 86.3 ± 14.8* 162.0 ± 24.5¶ 10.5 ± 20.0*¶
 CC 1:3 40.4 ± 7.0 12.6 ± 5.0 67.8 ± 10.8 70.2 ± 14.7 2.5 ± 1.0 100.9 ± 24.3*# 187.2 ± 25.0*# 26.5 ± 18.6#
Following 1:3 39.9 ± 7.0 11.7 ± 3.6 67.0 ± 11.1 71.6 ± 15.0 1.8 ± 0.6 77.6 ± 24.9 144.3 ± 16.3 22.2 ± 22.2
 CE 1:1 47.1 ± 7.0*$ 17.1 ± 3.5$ 74.6 ± 6.9*$ 73.4 ± 29.1* 2.9 ± 0.5 97.7 ± 24.5*$ 179.0 ± 52.5*$ 25.4 ± 15.0$
 CE 1:3 40.1 ± 6.8# 11.9 ± 4.1# 68.2 ± 10.0# 72.1 ± 15.1# 2.6 ± 0.9 93.6 ± 27.6$# 164.9 ± 15.9*$# 28.9 ± 21.8
Following 1:3 39.4 ± 6.8 11.5 ± 3.8 67.0 ± 9.2 73.4 ± 15.5 2.0 ± 0.5 83.9 ± 20.4 146.9 ± 16.5 28.3 ± 18.9
 CL 1:1 41.4 ± 3.8 13.5 ± 0.5 69.4 ± 4.1 105.4 ± 26.5 2.6 ± 0.5 84.1 ± 5.4 156.6 ± 10.4 1.5 ± 0.6
 CL 1:3 38.7 ± 0.9 18.6 ± 0.6 49.7 ± 0.5 43.5 ± 1.0 3.8 ± 0.0 58.8 ± 1.3 177.1 ± 0.2 -6.3 ± 4.7
Following 1:3 39.1 ± 0.9 15.5 ± 0.0 50.2 ± 0.5 46.3 ± 0.7 1.2 ± 0.1 26.3 ± 1.5 120.0 ± 0.6 -17.9 ± 1.1
control 1:1 47.6 ± 6.2 16.8 ± 3.6 76.4 ± 6.5 76.6 ± 31.9 3.1 ± 0.4 92.0 ± 21.6 149.3 ± 36.2 37.5 ± 15.6
control 1:3 40.0 ± 6.7 11.7 ± 3.2 67.4 ± 12.7 70.8 ± 16.6 1.8 ± 0.3 72.4 ± 35.7 149.9 ± 16.6 24.2 ± 18.2
Values are mean ± standard deviation. P
LV
 = Left ventricular pressure; D = Average diastolic; S = Average systolic; SV = Stroke volume; Q
cor
 = Coronary blood flow; 
EC/CC/LC = Early/conventional/late inflation and conventional deflation timing; CE/CC/CL = Conventional inflation and early/conventional/late deflation timing; 
* = P<0.05 compared to control; ¶ = P<0.05 compared to 1:3; $ = P<0.05 compared to CC; # = P<0.05 compared to the following beat (1:3 group only).
at several timing combinations in terms of edP
ao
 reduction, 
and during 1:1 support EC provided lower edP
ao
 than CC 
(59.5 ± 7.8 mmHg [EC], 63.4 ± 11.1 mmHg [CC]). Assistance 
frequency 1:1 reduced SP
LV
 more than 1:3 at all timing com-
binations except CE, and there was no trigger timing at 1:1 
that provided lower SP
LV
 than CC (69.1 ± 6.5 mmHg [CC], 
76.4 ± 6.5 mmHg [control]). Findings for average per beat 
P
LV
 were qualitatively identical to SP
LV
, while DP
LV
 scarcely 
presented statistically significant changes, overall (Tab. II 
and Fig. 3A).
An increase in stroke volume compared to control took 
place only during 1:1 support at CC, although 1:3 support 
did show some efficiency compared to values without IABP. 
No trigger timing provided greater increase in SV than CC 
at 1:1 (88.5 ± 34.4 ml [CC], 76.6 ± 31.9 ml [control]). Back-
flow increased significantly with both support frequencies at 
EC compared to control and to the following beat, but this 
increase was significantly higher with 1:3 (67% [1:3], 42% 
[1:1]). 1:3 showed superior efficiency over 1:1 in terms of 
DQ
cor
 augmentation (except for CE) and at 1:3 no trigger tim-
ing produced higher DQ
cor
 than CC (187.2 ± 25.0 ml/min [CC], 
149.9 ± 16.6 ml/min [control]). The results for Q
cor
 are similar 
to those of DQ
cor
, with small differences due to variations in 
SQ
cor
 (Tab. II, Fig. 3B).
Discussion
Summary of findings
The effect of varying IABP assistance frequency and trig-
ger timing on various quantities derived from pressure and 
flow measurements in the ascending aorta of healthy sheep 
was investigated. P
aug
 was enhanced by both assistance fre-
quencies alike. Assistance frequency 1:1 was more beneficial 
in reducing edP
ao
 and SP
LV
 and increasing SV, while frequency 
1:3 was more beneficial in increasing DQ
cor
. The trigger tim-
ings that resulted in best IABP performance at the above fre-
quencies were EC and CC for P
aug
 (at frequency 1:3 and 1:1, 
respectively), EC for edP
ao
, and CC for SP
LV
, SV and DQ
cor
.
Hemodynamic effects of assistance frequency and timing
The most commonly quoted benefit of IAB inflation is P
aug
, 
leading to increased DQ
cor
 in non-stenotic or moderately ste-
notic coronary vessels, due to the increased aortic-coronary 
pressure gradient (1, 13-15). Despite enhanced diastolic P
ao
 
always achieved with IABP support in our healthy animal pop-
ulation (Tab. I), this increase was not always accompanied by 
an increase in DQ
cor
. It is likely that the native autoregulatory 
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mechanisms that govern myocardial perfusion precluded a 
simple linear relationship between P
aug
 and DQ
cor
 (16).
There was no timing combination that yielded both P
aug
 
and DQ
cor
 better than CC at a single assistance frequency in 
this study. During 1:3 support EC timing improved P
aug
 com-
pared to CC, while DQ
cor
 was augmented more at CC. During 
1:1 support CC timing was optimal for P
aug
, whereas DQ
cor 
was 
increased more with CE timing. Despite the apparent benefit 
of EC timing on P
aug
, with early inflation starting while the aor-
tic valve is still open, the IABP may displace blood directly into 
the LV, interrupting the phase of late ejection. During the sys-
tole that immediately precedes early IAB inflation at 1:3 sup-
port, a reduction in SV from 70.8 ± 16.6 ml at control down 
to 67.4 ± 16.2 ml (P<0.0005), directly followed by increased 
backflow from 1.8 ± 0.3 ml at control up to 3.0 ± 0.3 ml 
(P<0.0001), provide further evidence of a detrimental effect 
of early inflation on LV mechanics. The beneficial effect of CE 
timing on DQ
cor
 indicates that early deflation did not lead to 
coronary blood flow stealing in our experiments.
Although DQ
cor
 overall benefited more by 1:3, this frequen-
cy enhances DQ
cor
 only every third beat, whereas 1:1 increases 
myocardial perfusion every beat. Therefore, during 1:1 sup-
port the DQ
cor
 enhancement provided by both CC (13 ml/min) 
and CE (30 ml/min) could match or significantly exceed, re-
spectively, the benefit of 1:3 (37 ml/min) (Tab. II).
A decrease in myocardial oxygen demand, generated 
through edP
ao
 reduction and thus reduction in afterload, is a 
widely reported outcome of IAB deflation (2). A statistically 
significant reduction in edP
ao
 with IABP support was observed 
under most timing interventions, but only at assistance fre-
quency 1:1 (Tab. I). A resulting drop in SP
LV
, indicating a de-
crease in myocardial metabolic demand, was also observed 
at 1:1 but not 1:3 (Fig. 3A). This superiority of 1:1 was con-
firmed statistically at several triggering timings for both edP
ao
 
and SP
LV
, with 1:3 either not affecting or even stimulating in-
creases in these parameters. This apparent inferiority of 1:3 
could be due to population differences between the 1:1 and 
1:3 groups (such as baseline P
ao
).
Clinical implications
All hemodynamic findings from the animal cohort that we 
studied indicate that there is no single assistance frequency 
that shows superiority to other frequencies by improving 
uniformly all investigated hemodynamic parameters. For in-
stance, DQ
cor
 appeared to benefit more by 1:3 support, while 
1:1 support was more beneficial for parameters related to 
afterload reduction and myocardial metabolic demand. Fur-
thermore, even though there were unconventional IABP trig-
ger timings that benefited some hemodynamic parameters 
more than CC, there was not a single timing that demonstrat-
ed superiority to CC across all parameters. Hence, despite 
not maximizing the benefit for all hemodynamic parameters, 
CC could nonetheless still be the favored choice for balanced 
support.
However, the improved performance of some uncon-
ventional trigger timings compared to CC warrants further 
investigation. CC timing appears to have been established 
early on, based on theoretical indications and lack of evi-
dence against it, and has never been challenged through ex-
tensive and thorough testing. Our study provides indication 
that CC timing might well not be the ultimate timing mode 
for every patient. For example, a patient receiving IABP sup-
port as a prophylactic measure during a high-risk coronary 
procedure might benefit more by inflation (enhancement in 
coronary blood flow), while a patient in cardiogenic shock 
might benefit more by deflation (reduction in afterload). Our 
Fig. 3 - Average systolic (S), average diastolic (D) and average per 
beat (•) left ventricular pressure (P
LV
) (A) and coronary blood flow 
(Q
cor
) (B). The top panels correspond to the 1:1 group and the bot-
tom panels to the 1:3 group. Data are presented as overall means 
for the various IABP trigger timings, for the corresponding follow-
ing beats (1:3 group only) and for the control beats. The error bars 
represent standard deviations.
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study has provided evidence that the optimal timing for the 
above 2 possible patient groups might be different and CC 
might not be optimal for either of them, calling altogether 
for open-mindedness about investigating alternatives to the 
established timing. It thus promotes the idea of personalized 
rather than generalized patient therapy for the achievement 
of higher IABP therapeutic efficiency, with a choice of infla-
tion/deflation timing that prioritizes the recovery of those 
hemodynamic indices that are more in need of support in the 
unassisted circulation.
In current practice, both frequency weaning and volume 
weaning are legitimate options for withdrawal from full 1:1 
IABP support, prescribing a gradual reduction in support fre-
quency and IAB augmentation volume, respectively (17, 18). 
In this work, a large number of parameters benefited more by 
1:1 than 1:3, in agreement with other studies (7), suggesting 
that the support provided per assisted cardiac cycle during 
1:3 does not meet the therapeutic effects provided during 
1:1. Further investigation is warranted to explore whether 
the above findings will evolve into a clear advantage of vol-
ume weaning within the context of a clinical trial.
The onset of inflation and deflation with respect to other 
events during the cardiac cycle are unquestionably critical 
for IABP performance, but the resulting duration of inflation 
could also be of relevance. Trigger timing with onset of infla-
tion or deflation that are considered unsafe according to the 
current practise, for example EC and CL, might still yield posi-
tive outcomes because they accommodate longer duration of 
inflation compared to CC. Likewise, trigger timings that result 
in shortened duration of inflation compared to CC, such as 
LC and CE, might lead to adverse outcomes despite generally 
considered not harmful.
The clinical significance of small (but statistically signifi-
cant) hemodynamic changes induced by the IABP warrants 
further investigation.
Limitations
The critically ill patients supported with the IABP are typi-
cally old, with impaired cardiac function, irregular heart rate, 
compromised coronary autoregulatory mechanisms, and ath-
erosclerotic vessels. These pathophysiological abnormalities 
are not replicated by our animal model and may have an im-
pact on the performance of the IABP. This choice was made in 
order to avoid introducing pathophysiological variability in a 
small animal cohort.
The most desired outcome of IABP support is a reduction 
in oxygen demand coupled with improved oxygen delivery. 
The impact of our study would therefore be enhanced with 
measures of myocardial oxygen supply and demand during 
frequency and timing manipulations.
A large number of statistical tests were conducted in the 
present study (22 for each variable of interest) and no P-value 
adjustment for multiple testing was made. Multiple compari-
sons can result in an increased risk of type I errors, but on the 
other hand P-value adjustments increase the chance of making 
type II errors. Because of the exploratory nature of the pres-
ent study, the possibility of investigating leads that might turn 
out to be false due to type I errors was deemed preferable to 
potentially missing important findings due to type II errors.
The present work does not provide definitive clinical recom-
mendations for alternative timings that might deliver better he-
modynamic support than CC, since we tested a small number of 
animals that were healthy, as we have already acknowledged. 
However, our results suggest that based on the investigated 
parameters, the currently established trigger timing does not 
appear to be optimal and further investigation is encouraged.
Conclusions
No single IABP assistance frequency showed superiority 
to other frequencies by uniformly benefiting all investigated 
hemodynamic parameters. Likewise, conventional trigger 
timing did not aid evenly all investigated parameters more 
than unconventional trigger timings. These findings suggest 
that a choice of optimal frequency and timing might need to 
be made based on individualized hemodynamic needs rather 
than as a generalized protocol.
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